[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Veradermics Incorporated (MANE)

Veradermics Incorporated (MANE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,830,716
  • Shares Outstanding, K 41,779
  • Annual Sales, $ 0 K
  • Annual Income, $ -69,995 K
  • EBIT $ 0 M
  • EBITDA $ 0 M
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
90.36 +1.47%
on 06/05/26
117.71 -22.11%
on 05/06/26
-23.11 (-20.13%)
since 05/05/26
3-Month
47.14 +94.51%
on 03/06/26
117.71 -22.11%
on 05/06/26
+43.07 (+88.58%)
since 03/05/26

Most Recent Stories

More News
Achieve Life Sciences Appoints Jeffrey Farrow and Reid Waldman, MD to Board of Directors

SEATTLE and VANCOUVER, British Columbia, June 02, 2026 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (“Achieve” or the “Company”) (Nasdaq: ACHV), a late-stage specialty pharmaceutical company...

MANE : 91.69 (-9.42%)
TARS : 59.28 (-1.76%)
ACHV : 5.13 (-3.02%)
Veradermics to Present at Upcoming June Investor Conferences

Veradermics, Incorporated (NYSE: MANE), a dermatologist-founded, late clinical-stage biopharmaceutical company focused on developing innovative therapeutics for pattern hair loss, today announced that...

MANE : 91.69 (-9.42%)
Veradermics Announces Poster Presentation on Topline Results from Phase 2/3 ‘302’ Study of VDPHL01 at the 2026 World Congress for Hair Research

Veradermics, Incorporated (NYSE: MANE), a dermatologist-founded, late clinical-stage biopharmaceutical company focused on developing innovative therapeutics for pattern hair loss, today announced that...

MANE : 91.69 (-9.42%)
Veradermics Announces Two Poster Presentations on VDPHL01 at the 2026 Music City SCALE Symposium

Veradermics, Incorporated (NYSE: MANE), a dermatologist-founded, late clinical-stage biopharmaceutical company focused on developing innovative therapeutics for pattern hair loss, today announced that...

MANE : 91.69 (-9.42%)
Veradermics: Q1 Earnings Snapshot

Veradermics: Q1 Earnings Snapshot

MANE : 91.69 (-9.42%)
Veradermics Reports First Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress

Positive topline results from Phase 2/3 Study ‘302’ position VDPHL01 to potentially become the first FDA-approved oral treatment for pattern hair loss in nearly 30 years ...

MANE : 91.69 (-9.42%)
Veradermics Announces Pricing of Upsized Public Offering and Private Placement

Veradermics, Incorporated (“Veradermics”) (NYSE: MANE), a dermatologist-founded, late clinical-stage biopharmaceutical company focused on developing innovative therapeutics for pattern hair loss, today...

MANE : 91.69 (-9.42%)
Veradermics Announces Launch of Public Offering

Veradermics, Incorporated (“Veradermics”) (NYSE: MANE), a dermatologist-founded, late clinical-stage biopharmaceutical company focused on developing innovative therapeutics for pattern hair loss, today...

MANE : 91.69 (-9.42%)
Tech Earnings Optimism Powers Stocks Higher

The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.12%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed down -0.13%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.01%. June E-mini...

ALK : 42.82 (+0.30%)
UAL : 105.73 (+0.75%)
AMAT : 453.01 (-9.71%)
SNDK : 1,559.32 (-11.39%)
VZ : 45.37 (+1.11%)
ADI : 401.39 (-6.38%)
TXN : 285.06 (-6.65%)
$IUXX : 28,957.60 (-4.77%)
ELV : 415.53 (+1.49%)
UNH : 399.47 (+0.76%)
ASML : 1,641.74 (-6.59%)
DPZ : 313.99 (+2.11%)
Stocks Slip as Higher Oil Prices Spur Inflation Concerns

The S&P 500 Index ($SPX ) (SPY ) today is down -0.12%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.30%. June E-mini S&P futures...

ALK : 42.82 (+0.30%)
UAL : 105.73 (+0.75%)
AMAT : 453.01 (-9.71%)
SNDK : 1,559.32 (-11.39%)
VZ : 45.37 (+1.11%)
ADI : 401.39 (-6.38%)
TXN : 285.06 (-6.65%)
$IUXX : 28,957.60 (-4.77%)
DPZ : 313.99 (+2.11%)
ZNU26 : 109-025s (-0.47%)
ESM26 : 7,400.50s (-2.64%)
NCLH : 18.75 (-1.99%)

Key Turning Points

3rd Resistance Point 110.34
2nd Resistance Point 106.08
1st Resistance Point 98.88
Last Price 91.69
1st Support Level 87.43
2nd Support Level 83.17
3rd Support Level 75.97

See More

52-Week High 117.71
Last Price 91.69
Fibonacci 61.8% 84.97
Fibonacci 50% 74.85
Fibonacci 38.2% 64.74
52-Week Low 32.00

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.